Waters 20 nov. 2025 What macro factors could drive Waters Corporation (WAZ) stock higher - Portfolio Update Report & Expert Approved Momentum Trade Ideas - newser.com #Waters Corporation #Portfolio Update
Agilent 20 nov. 2025 Why Agilent Technologies Inc. stock stays resilient - Stop Loss & Daily Stock Momentum Reports - newser.com #Agilent Technologies #Stop Loss
Agilent 19 nov. 2025 Measuring Agilent Technologies Inc.’s beta against major indices - July 2025 Trends & Free Real-Time Market Sentiment Alerts - newser.com #Agilent Technologies #Technologies Inc.’s
Waters 19 nov. 2025 Will Waters Corporation (WAZ) stock outperform energy sector in 2025 - Portfolio Update Report & Long-Term Safe Investment Plans - newser.com #Waters Corporation #Portfolio Update
Roche Media 19 nov. 2025 KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors - Yahoo Finance #Immunotherapeutics Announces #Announces Clinical
Agilent 19 nov. 2025 Is Agilent Technologies Inc. (AG8) stock prepared for digital transition - Weekly Investment Recap & AI Based Buy and Sell Signals - newser.com #Agilent Technologies #Weekly Investment
Promega Blog 18 nov. 2025 CRISPR/Cas9 Knock-In Tagging: Simplifying the Study of Endogenous Biology #Biology Understanding #Knock-In Tagging
Roche Media 18 nov. 2025 Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S. - PR Newswire #Announces Exclusive #Exclusive Agreement
Roche Media 18 nov. 2025 New experimental drug could transform care for cancer patients - The Independent #experimental drug #transform care
Roche Media 18 nov. 2025 Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? - simplywall.st #Stock Jump #Reassess Roche
PharmaVoice 18 nov. 2025 Amylin could reign supreme in the next wave of obesity drugs #weight management #critical readouts
PharmaVoice 17 nov. 2025 Developing a path forward in cancer cachexia #Pfizer scientists #cachexia Pfizer
Lonza News 16 nov. 2025 How Lonza Group AG (Common Stock) (LO3A) stock reacts to stronger dollar - Portfolio Risk Report & Free Long-Term Investment Growth Plans - newser.com #Portfolio Risk #Risk Report
Agilent 14 nov. 2025 Agilent Technologies (A): Is the Stock Undervalued After Recent Momentum Cools? - simplywall.st #Momentum Cools #Stock Undervalued
10x Genomics Blog 14 nov. 2025 10x Genomics Announces Chief Legal Officer Retirement - TipRanks #Genomics Announces #Announces Chief
10x Genomics Blog 11 nov. 2025 Piper Sandler Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq #Sandler Maintains #Neutral Recommendation
Roche Media 10 nov. 2025 Roche's experimental MS drug hits main goal in one of two key trials - Reuters #Roche experimental #drug hits
Roche Media 10 nov. 2025 Roche Rival Plunges On 'Unprecedented' Results In MS Treatment - Investor's Business Daily #Rival Plunges #Investor Business